Journal of Cardiac Failure
Volume 13, Issue 4 , Pages 269-274 , May 2007

Effect of Chronic Changes in Heart Rate on Congestive Heart Failure

Received 5 October 2006 ,Revised 4 December 2006 ,Accepted 5 December 2006.

References 

  1. Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol. 2005;28:710–721
  2. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzparick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29:709–715
  3. Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 1992;69:489–492
  4. Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004;110:247–252
  5. Takahashi M, Tsutsui H, Kinugawa S, et al. Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy. J Mol Cell Cardiol. 1998;30:1047–1057
  6. Coker ML, Thomas CV, Clair MJ, et al. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am J Physiol. 1998;274:H1516–H1523
  7. King MK, Coker ML, Goldberg A, et al. Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure. Circ Res. 2003;92:177–185
  8. Kajstura J, Zhang X, Liu Y, et al. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation. 1995;92:2306–2317
  9. Yamamoto T, Yano M, Kohno M, et al. Abnormal Ca2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure. Cardiovasc Res. 1999;44:146–155
  10. Pieske B, Kretschmann B, Meyer M, et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169–1178
  11. Van der Berg MP, van Veldhuinsen DJ, Crijns HJGM, Lie KI. Reversion of tachycardio-myopathy after β-blocker. [letter] Lancet. 1993;341:1667
  12. Wikstrand J, Hjalmarson A, Waagstein F, et al. MERIT-HF Study Group Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in Metoprolol CR/XL Randomized Intervention Trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol. 2002;40:491–498
  13. Lechst P, Escolano S, Golmard JL, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1997;96:2197–2295
  14. Gullestad L, Wikstrand J, Deedwania P, et al. for the MERIT-HF Study Group What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol. 2005;45:252–259
  15. Grassi G, Vailati S, Bertinieri G, et al. Heart rate as marker of sympathetic activity. J Hypertens. 1998;16:1635–1639
  16. Bristow MR, Lowes B. Low dose inotropic therapy for ambulatory heart failure. Coron Artery Disease. 1994;5:112–118
  17. Hasenfuss G, Holubarsch C, Hermann H-P, Astheimer K, Pieske B, Just H. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J. 1994;15:164–170
  18. Mulieri L, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation. 1992;85:1743–1750
  19. Vollmann D, Lüthje L, Schott P, Hasenfuss G, Unterberg-Buchwald C. Biventricular pacing improves the blunted force-frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation. 2006;113:953–959

 All decisions regarding this meanuscript were made by a guest editor.Funded by a grant from The American Heart Association, Mid-Atlantic Division.

PII: S1071-9164(06)01293-0

doi: 10.1016/j.cardfail.2006.12.001

Journal of Cardiac Failure
Volume 13, Issue 4 , Pages 269-274 , May 2007

Article Tools

* Image Usage & Resolution